CRISPR/Cas9 cccDNA delivery gene therapy hepatitis B virus

Journal

Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977

Informations de publication

Date de publication:
2022
Historique:
received: 25 05 2022
accepted: 15 06 2022
entrez: 18 7 2022
pubmed: 19 7 2022
medline: 19 7 2022
Statut: epublish

Résumé

Chronic hepatitis B virus (HBV) infection remains a major global health problem despite the availability of an effective prophylactic HBV vaccine. Current antiviral therapies are unable to fully cure chronic hepatitis B (CHB) because of the persistent nature of covalently closed circular DNA (cccDNA), a replicative template for HBV, which necessitates the development of alternative therapeutic approaches. The CRISPR/Cas system, a newly emerging genome editing tool, holds great promise for genome editing and gene therapy. Several

Identifiants

pubmed: 35847068
doi: 10.3389/fmicb.2022.953218
pmc: PMC9284033
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

953218

Informations de copyright

Copyright © 2022 Kayesh, Hashem, Kohara and Tsukiyama-Kohara.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Virology. 2015 May;479-480:672-86
pubmed: 25759099
Nat Biotechnol. 2016 Mar;34(3):334-8
pubmed: 26829317
Mol Ther. 2016 Aug;24(7):1258-66
pubmed: 27203444
Nat Genet. 2004 Jul;36(7):767-73
pubmed: 15208627
J Control Release. 2022 Feb;342:345-361
pubmed: 35026352
Viruses. 2012 May;4(5):847-77
pubmed: 22754652
Mol Ther. 2010 Jul;18(7):1357-64
pubmed: 20461061
Mol Ther Nucleic Acids. 2020 Jun 5;20:480-490
pubmed: 32278307
Int J Mol Sci. 2015 Oct 16;16(10):24751-71
pubmed: 26501275
Nat Rev Mol Cell Biol. 2019 Aug;20(8):490-507
pubmed: 31147612
N Engl J Med. 2014 Mar 6;370(10):901-10
pubmed: 24597865
Expert Opin Drug Deliv. 2018 Sep;15(9):905-913
pubmed: 30169977
J Nanobiotechnology. 2022 Jan 6;20(1):27
pubmed: 34991617
Nano Lett. 2015 Dec 9;15(12):8099-107
pubmed: 26529392
Rev Med Virol. 2006 May-Jun;16(3):167-86
pubmed: 16710837
Mol Ther Methods Clin Dev. 2021 Mar 03;21:121-132
pubmed: 33816645
Mol Ther Methods Clin Dev. 2017 Dec 01;8:87-104
pubmed: 29326962
Sci Rep. 2017 Dec 7;7(1):17113
pubmed: 29215041
Methods Mol Biol. 2019;1950:333-360
pubmed: 30783984
Adv Mater. 2019 Aug;31(33):e1902575
pubmed: 31215123
J Virol. 2002 Feb;76(3):1496-504
pubmed: 11773422
J Virol Methods. 2022 Jan;299:114334
pubmed: 34688781
Microbiology (Reading). 2005 Aug;151(Pt 8):2551-2561
pubmed: 16079334
Mol Biol (Mosk). 2019 Mar-Apr;53(2):311-323
pubmed: 31099781
World J Gastroenterol. 2015 Aug 28;21(32):9554-65
pubmed: 26327763
J Chromatogr B Biomed Sci Appl. 1999 Sep 24;732(2):411-23
pubmed: 10517364
Curr Pharm Biotechnol. 2013;14(1):46-60
pubmed: 23437936
Mol Ther. 2018 Feb 7;26(2):524-541
pubmed: 29292161
J Virol. 1999 Aug;73(8):7050-5
pubmed: 10400808
Virus Res. 2018 Jan 15;244:311-320
pubmed: 28087399
Cold Spring Harb Perspect Med. 2015 Jul 01;5(7):a021386
pubmed: 26134841
Mol Ther Nucleic Acids. 2018 Sep 7;12:242-253
pubmed: 30195763
Nat Rev Drug Discov. 2019 May;18(5):358-378
pubmed: 30710128
Front Cell Infect Microbiol. 2019 Mar 22;9:69
pubmed: 30968001
Front Cell Infect Microbiol. 2017 Mar 22;7:91
pubmed: 28382278
Mol Ther Methods Clin Dev. 2020 Oct 04;19:347-361
pubmed: 33145371
Mol Immunol. 2021 Feb;130:7-13
pubmed: 33340931
Cell Rep. 2017 Jul 18;20(3):750-756
pubmed: 28723575
Clin Microbiol Rev. 2008 Oct;21(4):583-93
pubmed: 18854481
Gene Ther. 2007 Jan;14(1):11-9
pubmed: 16929350
Biochemistry (Mosc). 2016 Jul;81(7):700-8
pubmed: 27449616
J Gen Virol. 2015 Aug;96(8):2252-2261
pubmed: 25904148
Haemophilia. 2012 Jul;18 Suppl 4:13-7
pubmed: 22726076
Sci Rep. 2015 Sep 03;5:13734
pubmed: 26334116
Antiviral Res. 2018 Apr;152:58-67
pubmed: 29458131
Microbiology (Reading). 2005 Mar;151(Pt 3):653-663
pubmed: 15758212
Science. 2018 Aug 31;361(6405):866-869
pubmed: 30166482
Methods Mol Biol. 2017;1507:81-94
pubmed: 27832534
Cell Rep. 2018 Feb 27;22(9):2227-2235
pubmed: 29490262
J Control Release. 2017 Nov 28;266:17-26
pubmed: 28911805
Discov Med. 2015 Apr;19(105):255-62
pubmed: 25977188
Trends Biotechnol. 2013 Jul;31(7):397-405
pubmed: 23664777
Nat Rev Genet. 2020 Apr;21(4):255-272
pubmed: 32042148
Cell. 2018 Mar 8;172(6):1239-1259
pubmed: 29522745
Front Microbiol. 2021 Jun 26;12:665184
pubmed: 34254007
Mol Ther Nucleic Acids. 2014 Dec 16;3:e216
pubmed: 25514649
Nat Commun. 2019 Sep 30;10(1):4439
pubmed: 31570731
Sci Rep. 2020 Dec 8;10(1):21474
pubmed: 33293588
Theranostics. 2014 Jan 15;4(3):240-55
pubmed: 24505233
Viruses. 2019 Jan 04;11(1):
pubmed: 30621179
Int J Nanomedicine. 2016 Oct 31;11:5645-5669
pubmed: 27920520
Viruses. 2021 Apr 28;13(5):
pubmed: 33924851
Antiviral Res. 2015 Jun;118:110-7
pubmed: 25843425
Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10220-5
pubmed: 20479244
Mol Cell Biol. 2003 May;23(10):3550-7
pubmed: 12724413
Sci Adv. 2019 Apr 03;5(4):eaav7199
pubmed: 30949579
Nature. 2015 Jul 23;523(7561):481-5
pubmed: 26098369
Hear Res. 2020 Sep 1;394:107912
pubmed: 32067799
Science. 2007 Mar 23;315(5819):1709-12
pubmed: 17379808
Adv Drug Deliv Rev. 2021 Jan;168:3-29
pubmed: 31759123
Mol Ther. 2010 Jan;18(1):80-6
pubmed: 19904234
Mol Ther Methods Clin Dev. 2018 Jun 15;10:105-112
pubmed: 30073181
Mol Ther Nucleic Acids. 2015 Nov 17;4:e264
pubmed: 26575098
Virus Res. 2020 Dec;290:198191
pubmed: 33049308
Gene Ther. 2015 May;22(5):404-12
pubmed: 25652100
mBio. 2022 Apr 26;13(2):e0288821
pubmed: 35389262
Mol Ther Methods Clin Dev. 2020 Jun 03;18:259-268
pubmed: 32637455
Mol Ther Nucleic Acids. 2014 Aug 19;3:e186
pubmed: 25137139
J Virol. 2005 Aug;79(15):9933-44
pubmed: 16014954
Viruses. 2021 Aug 18;13(8):
pubmed: 34452505
Gut. 2015 Dec;64(12):1972-84
pubmed: 26048673
Int J Mol Sci. 2015 Nov 02;16(11):26077-86
pubmed: 26540039
J Control Release. 2021 Feb 10;330:61-71
pubmed: 33333121
Elife. 2021 Mar 10;10:
pubmed: 33689678
Acc Chem Res. 2019 Jun 18;52(6):1555-1564
pubmed: 31099553
Drug Deliv. 2018 Nov;25(1):1234-1257
pubmed: 29801422
Cells. 2020 Jul 02;9(7):
pubmed: 32630835
Mol Ther. 2016 Jun;24(6):1042-1049
pubmed: 27019999
Nat Rev Mater. 2019 Nov;4:726-737
pubmed: 34094589
J Mol Evol. 2005 Feb;60(2):174-82
pubmed: 15791728
J Pharm Sci. 2020 Jan;109(1):62-67
pubmed: 31589876
Acta Pharm Sin B. 2021 Aug;11(8):2150-2171
pubmed: 34522582
Curr Top Microbiol Immunol. 2010;343:195-224
pubmed: 20376613
Hepatol Commun. 2018 Nov 15;3(1):8-19
pubmed: 30619990
Vaccines (Basel). 2020 May 11;8(2):
pubmed: 32403281
N Engl J Med. 2011 Dec 22;365(25):2357-65
pubmed: 22149959
Virus Res. 2016 Jun 2;217:125-32
pubmed: 27049051
Cell Res. 2017 Mar;27(3):440-443
pubmed: 28117345
J Control Release. 2014 Jun 10;183:124-37
pubmed: 24657948
ACS Infect Dis. 2019 May 10;5(5):688-702
pubmed: 30539633
Hepatology. 2009 May;49(5 Suppl):S13-21
pubmed: 19399811
Cell Chem Biol. 2016 Jan 21;23(1):57-73
pubmed: 26933736
Biomolecules. 2020 May 30;10(6):
pubmed: 32486234
Front Genome Ed. 2021 Jan 28;2:617910
pubmed: 34713240
Curr Gene Ther. 2014;14(2):86-100
pubmed: 24588706
Science. 2012 Aug 17;337(6096):816-21
pubmed: 22745249
Int J Mol Sci. 2020 Aug 28;21(17):
pubmed: 32872311
Gene Ther. 2012 Feb;19(2):162-8
pubmed: 21993172
Sci Rep. 2017 Aug 7;7(1):7401
pubmed: 28785016
Hum Vaccin Immunother. 2021 Jul 3;17(7):2268-2272
pubmed: 33522392
Angew Chem Int Ed Engl. 2017 Jan 19;56(4):1059-1063
pubmed: 27981708
Mol Ther. 2012 Apr;20(4):699-708
pubmed: 22273577
Front Immunol. 2021 Feb 19;12:638447
pubmed: 33679796
Nat Methods. 2020 Dec;17(12):1179-1182
pubmed: 33154568
Science. 2014 Nov 28;346(6213):1258096
pubmed: 25430774
J Drug Target. 2014 Oct 7;22(3):232-241
pubmed: 24328572
N Engl J Med. 2017 Dec 7;377(23):2215-2227
pubmed: 29211678
Hepatol Commun. 2022 Jul;6(7):1652-1663
pubmed: 35338607
Science. 2013 Feb 15;339(6121):823-6
pubmed: 23287722
BioDrugs. 2017 Aug;31(4):317-334
pubmed: 28669112
Int J Biol Sci. 2016 Aug 05;12(9):1104-13
pubmed: 27570484
Mol Ther Methods Clin Dev. 2020 Nov 26;20:258-275
pubmed: 33473359
Nat Biotechnol. 2003 Jun;21(6):639-44
pubmed: 12740585
Biomater Sci. 2019 Mar 26;7(4):1240-1261
pubmed: 30734775
Front Genet. 2021 May 12;12:673286
pubmed: 34054927
Nat Med. 2019 Feb;25(2):249-254
pubmed: 30692695
Science. 2013 Feb 15;339(6121):819-23
pubmed: 23287718
Sci Rep. 2015 Jun 02;5:10833
pubmed: 26035283
Gene Ther. 2002 Dec;9(24):1730-4
pubmed: 12457288
Curr Gene Ther. 2005 Jun;5(3):265-71
pubmed: 15975004
Front Immunol. 2018 Sep 11;9:2080
pubmed: 30254645
Nat Med. 2019 Feb;25(2):242-248
pubmed: 30374197

Auteurs

Mohammad Enamul Hoque Kayesh (MEH)

Joint Faculty of Veterinary Medicine, Transboundary Animal Diseases Centre, Kagoshima University, Kagoshima, Japan.
Department of Microbiology and Public Health, Faculty of Animal Science and Veterinary Medicine, Patuakhali Science and Technology University, Barishal, Bangladesh.

Md Abul Hashem (MA)

Joint Faculty of Veterinary Medicine, Transboundary Animal Diseases Centre, Kagoshima University, Kagoshima, Japan.

Michinori Kohara (M)

Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.

Kyoko Tsukiyama-Kohara (K)

Joint Faculty of Veterinary Medicine, Transboundary Animal Diseases Centre, Kagoshima University, Kagoshima, Japan.

Classifications MeSH